Sign in
4

Changes in Ownership

BlossomHill Therapeutics, Inc. Filed Acc 0002143905-26-000003

General Counsel bought 4,700 shares at an average $15.89 ($74,700)

  • General Counsel acquired 22,687 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Liptak Vincent Paul General Counsel 2026-08-07 Purchase +2,500 $15.80 $39,500 109,212 D: show line 1 in the form
Liptak Vincent Paul General Counsel 2026-08-10 Purchase +2,200 $16.00 $35,200 111,412 D: show line 2 in the form
Liptak Vincent Paul General Counsel 2026-08-10 Conversion +22,687 22,687 I: show line 3 in the form
Open-market purchases · 4,700 sh · avg $15.89 · $74,700

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Liptak Vincent Paul General Counsel 2026-08-06 Grant or award · Employee Stock Option (Right to Buy) +46,561 46,561 D: show line 4 in the form
Liptak Vincent Paul General Counsel 2026-08-10 Conversion · Series B Preferred Stock −22,687 0 I: show line 5 in the form
Loading xslF345X06/form4-08102026_100801.xml…